BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 26, 2014
View Archived Issues
Pfizer researchers design nicotine vaccines with higher avidity
Read More
Gilead's GS-5806 effective in phase IIa RSV trial
Read More
TxCell's Col-Treg receives Advanced Therapy Medicinal Product designation
Read More
Extended recombinant PTH treatment demonstrates good efficacy for hypoparathyroidism
Read More
Novel uPAR-derived peptide tested for ocular angiogenesis-related diseases
Read More
Isis Pharmaceuticals reports data for ISIS-FXI-Rx in prevention of venous thrombosis
Read More
Dabigatran etexilate antidote progresses into next stage of clinical investigation
Read More
Novel non-retinoid therapeutic for AMD significantly reduces RBP4 plasma levels
Read More
H3 Biomedicine and Selvita achieve milestone in oncology collaboration
Read More
Bifunctional shRNA shows efficacy for the treatment of Ewing's sarcoma
Read More
Novel patent describes Wnt signaling inhibitors
Read More
Imatinib receives FDA orphan drug designation for PML
Read More
Nerviano Medical Sciences reports discovery of new PARP-1 inhibitors
Read More
Volitinib enters phase II trial in renal cell carcinoma
Read More
Toray Industries discloses nAChR alpha-7 agonists
Read More
Emory University synthesizes novel 7,8-dihydroxyflavone prodrugs
Read More
NeurOp selects development candidate for subarachnoid hemorrhage
Read More
Forxiga launched in Japan for the treatment of type 2 diabetes
Read More
Taisho Pharmaceutical launches Lusefi in Japan
Read More
Astellas launches Xtandi in Japan for prostate cancer
Read More
FDA approves dalbavancin for bacterial skin and skin structure infections
Read More
Vectibix plus FOLFOX approved in U.S. for wild-type KRAS metastatic colorectal cancer
Read More
GSK submits regulatory submission for umeclidinium monotherapy in Japan
Read More
Lonsurf combination tablet scheduled for launch in Japan
Read More
CHMP issues positive opinion for Translarna for nonsense mutation DMD
Read More
Dainippon proposes changes to prepare for global development of business
Read More
EMA committee recommends approval of obinutuzumab
Read More